Tirzepatide is a synthetic research peptide of thirty-nine amino acids in the GIP/GLP-1 dual-agonist class — a two-target compound in the incretin research collection.
We stock it as a single-lot reference standard, characterised for third-party analysis, with the certificate for your lot published on release to its verification page.
Its interest is its class and its place in the collection: a two-target incretin compound that sits between the single-target and triple-target reference peptides researchers line up beside it. Purity is stated as one specification and verified for each lot.
For laboratory research use only. Not for human or veterinary use.